GSK-LSD1, an LSD1 inhibitor, quashes SARS-CoV-2-triggered cytokine release syndrome in-vitro
- Authors
- Hong, Kyung Soo; Ahn, June Hong; Jang, Jong Geol; Lee, Jong Ho; Kim, Hong Nam; Kim, Dongha; Lee, Wonhwa
- Issue Date
- 2020-12-17
- Publisher
- SPRINGERNATURE
- Citation
- SIGNAL TRANSDUCTION AND TARGETED THERAPY, v.5, no.1
- ISSN
- 2095-9907
- URI
- https://pubs.kist.re.kr/handle/201004/117673
- DOI
- 10.1038/s41392-020-00391-5
- Appears in Collections:
- KIST Article > 2020
- Files in This Item:
There are no files associated with this item.
- Export
- RIS (EndNote)
- XLS (Excel)
- XML
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.